MeSH term
Frequency | Condition_Probility | Aged | 6 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 25 | 0.0 |
Humans | 99 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 13 | 0.0 |
Chemokines/*physiology | 3 | 9.0 |
Animals | 26 | 0.0 |
Chemokines, CC/*pharmacology | 3 | 14.0 |
Chemotaxis, Leukocyte/physiology | 2 | 10.0 |
In Vitro | 6 | 0.0 |
Mice | 20 | 0.0 |
Research Support, Non-U.S. Gov't | 66 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 38 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 14 | 0.0 |
Cells, Cultured | 31 | 0.0 |
Chemokines/*metabolism | 4 | 7.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Monocyte Chemoattractant Protein-1/metabolism | 2 | 3.0 |
Immunohistochemistry | 4 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Cell Line | 7 | 0.0 |
Hamsters | 2 | 0.0 |
Lung/virology | 2 | 22.0 |
Mice, Inbred BALB C | 4 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Calcium/metabolism | 5 | 0.0 |
Chemokines/*biosynthesis | 3 | 10.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Phosphorylation | 5 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Transport | 2 | 0.0 |
Time Factors | 6 | 0.0 |
Transfection | 4 | 0.0 |
Comparative Study | 14 | 0.0 |
Ligands | 2 | 0.0 |
RNA, Messenger/biosynthesis | 8 | 0.0 |
Signal Transduction/genetics/immunology | 2 | 2.0 |
Th2 Cells/immunology | 2 | 1.0 |
Cytokines/*immunology | 2 | 2.0 |
Killer Cells, Natural/*immunology | 2 | 0.0 |
Cell Movement/physiology | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Monocyte Chemoattractant Protein-1/pharmacology | 2 | 9.0 |
RANTES/pharmacology | 2 | 3.0 |
Recombinant Proteins/pharmacology | 4 | 0.0 |
Cell Adhesion Molecules/metabolism | 2 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Up-Regulation | 6 | 0.0 |
Arthritis, Rheumatoid/*immunology | 3 | 1.0 |
Chemokines, CXC/*physiology | 2 | 5.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Interleukin-8/*biosynthesis | 2 | 3.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Monocyte Chemoattractant Protein-1/*physiology | 2 | 20.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Rats | 4 | 0.0 |
Receptors, Chemokine/*biosynthesis | 4 | 10.0 |
Adult | 14 | 0.0 |
CD8-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Chemotaxis, Leukocyte/immunology | 2 | 3.0 |
Flow Cytometry/methods | 2 | 0.0 |
Receptors, Chemokine/*metabolism | 3 | 2.0 |
Chemokines/*immunology | 3 | 15.0 |
GTP-Binding Protein alpha Subunits, Gi-Go/metabolism | 2 | 5.0 |
Signal Transduction | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Fibroblasts/*metabolism/pathology | 2 | 8.0 |
Gene Expression Regulation | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 9 | 0.0 |
Cytokines/biosynthesis/genetics | 2 | 3.0 |
Calcium/physiology | 2 | 0.0 |
Chemokines/*biosynthesis/genetics | 3 | 21.0 |
Cell Division | 2 | 0.0 |
Flow Cytometry | 5 | 0.0 |
Phenotype | 3 | 0.0 |
Monocyte Chemoattractant Protein-1/*metabolism | 4 | 12.0 |
Monocytes/metabolism | 2 | 0.0 |
Chemokines/biosynthesis | 2 | 5.0 |
*Monocyte Chemoattractant Protein-1 | 3 | 60.0 |
Cell Movement/immunology | 2 | 2.0 |
Monocytes/immunology/metabolism | 2 | 4.0 |
Interleukin-8/biosynthesis/genetics | 3 | 12.0 |
Quinolinic Acid/*pharmacology | 2 | 40.0 |
RANTES/biosynthesis/genetics | 2 | 33.0 |
Receptors, Chemokine/*genetics | 2 | 2.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Fetus | 2 | 0.0 |
*HIV-1 | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Immunity, Natural | 2 | 0.0 |
RNA, Messenger/drug effects/metabolism | 2 | 1.0 |
Receptors, Chemokine/*antagonists & inhibitors/physiology | 2 | 28.0 |
Astrocytes/*drug effects/metabolism | 2 | 25.0 |
Base Sequence | 4 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
Monocyte Chemoattractant Protein-1/*blood | 4 | 28.0 |
Statistics, Nonparametric | 3 | 0.0 |
Culture Media, Conditioned | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Prognosis | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Mitogen-Activated Protein Kinases/*physiology | 2 | 2.0 |
Mice, Knockout | 2 | 0.0 |
Monocyte Chemoattractant Protein-1/*pharmacology | 3 | 25.0 |
Pertussis Toxin/pharmacology | 2 | 3.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Interleukin-1/pharmacology | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 5 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Intercellular Signaling Peptides and Proteins/metabolism | 2 | 2.0 |
Mice, Transgenic | 2 | 0.0 |
Up-Regulation/genetics | 2 | 2.0 |
Th1 Cells/*immunology | 2 | 1.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Culture Media, Serum-Free/pharmacology | 2 | 1.0 |
*Gene Expression Profiling | 3 | 0.0 |
Child | 3 | 0.0 |
NF-kappa B/physiology | 2 | 2.0 |
Cytokines/genetics | 2 | 1.0 |
Disease Progression | 4 | 0.0 |
Inflammation Mediators/*metabolism | 2 | 3.0 |
Down-Regulation/drug effects | 3 | 1.0 |
Chemokines/*genetics | 4 | 18.0 |
Monocyte Chemoattractant Protein-1/*genetics | 2 | 10.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 3 | 0.0 |
Cell Movement | 3 | 0.0 |
Macrophages/pathology | 2 | 1.0 |
Molecular Sequence Data | 3 | 0.0 |
Monocyte Chemoattractant Protein-1/genetics | 2 | 10.0 |
Coculture Techniques | 3 | 0.0 |
Lymph Nodes/pathology | 2 | 0.0 |
Neovascularization, Physiologic/*drug effects | 2 | 2.0 |
Anti-HIV Agents/*pharmacology | 2 | 1.0 |
Receptors, Chemokine/*antagonists & inhibitors | 2 | 11.0 |
Signal Transduction/drug effects | 3 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Receptors, Chemokine/genetics | 2 | 4.0 |
Interleukin-1/*pharmacology | 2 | 0.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Chemotaxis, Leukocyte/*drug effects | 2 | 3.0 |
Gene Expression Profiling | 2 | 0.0 |
Cell Movement/drug effects | 2 | 0.0 |
Cell Movement/*immunology | 2 | 2.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
